approval · primary record
INSULIN GLARGINE
FDA · BLA · 2026-03-12
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-03-12 |
| Brand | SOLIQUA 100/33 |
| Sponsor | SANOFI-AVENTIS US |
| Route | SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:12.411Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:INSULIN GLARGINE:2026-03-12
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.